What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
The scientist’s investigation covers issues in Internal medicine, Odds ratio, Risk factor, Case-control study and Immunology.
His studies deal with areas such as Gastroenterology, Endocrinology, Single-nucleotide polymorphism and Oncology as well as Internal medicine.
His Oncology research is multidisciplinary, incorporating perspectives in Carcinoma and Pathology.
His Odds ratio research is multidisciplinary, relying on both Confidence interval, Colorectal adenoma, Etiology, Confounding and Physiology.
His Risk factor research integrates issues from Cancer, Absolute risk reduction, Genetic variability, Prospective cohort study and Red meat.
His study in Case-control study is interdisciplinary in nature, drawing from both Minor allele frequency, Quartile, Cohort and Genotype.
His most cited work include:
- Interleukin-1 polymorphisms associated with increased risk of gastric cancer (2024 citations)
- Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies (1431 citations)
- NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. (509 citations)
What are the main themes of his work throughout his whole career to date?
Nathaniel Rothman mostly deals with Internal medicine, Odds ratio, Oncology, Cancer and Case-control study.
Nathaniel Rothman has included themes like Gastroenterology, Endocrinology, Single-nucleotide polymorphism and Immunology in his Internal medicine study.
The various areas that Nathaniel Rothman examines in his Odds ratio study include Body mass index, Surgery, Quartile, Confidence interval and Risk factor.
His Oncology research is multidisciplinary, incorporating perspectives in Bladder cancer and Pathology.
His work investigates the relationship between Cancer and topics such as Lung cancer that intersect with problems in Adenocarcinoma.
His Case-control study research is multidisciplinary, relying on both Epidemiology and Physiology.
He most often published in these fields:
- Internal medicine (39.38%)
- Odds ratio (26.93%)
- Oncology (23.41%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (39.38%)
- Oncology (23.41%)
- Genome-wide association study (12.86%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Genome-wide association study, Odds ratio and Cancer are his primary areas of study.
His study connects Gastroenterology and Internal medicine.
His work deals with themes such as Lymphoma, Risk factor, Pathology and Genotype, which intersect with Oncology.
Genetics and Single-nucleotide polymorphism are the two main areas of interest in his Genome-wide association study studies.
His Odds ratio research includes elements of Bladder cancer, Body mass index, Quartile and Cohort.
Nathaniel Rothman works mostly in the field of Case-control study, limiting it down to topics relating to Kidney cancer and, in certain cases, Exposure assessment.
Between 2015 and 2021, his most popular works were:
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors (94 citations)
- Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer (85 citations)
- Mosaic loss of chromosome Y is associated with common variation near TCL1A (76 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Nathaniel Rothman spends much of his time researching Internal medicine, Odds ratio, Genome-wide association study, Oncology and Genetics.
His Prospective cohort study, Case-control study, Confidence interval, Body mass index and Cancer study are his primary interests in Internal medicine.
The various areas that Nathaniel Rothman examines in his Odds ratio study include Bladder cancer, Gastroenterology, Immunology and Telomere.
His Genome-wide association study study is focused on Single-nucleotide polymorphism in general.
His Single-nucleotide polymorphism research incorporates elements of Adenocarcinoma and Genetic architecture.
The concepts of his Oncology study are interwoven with issues in Carcinoma, Pancreatic cancer and Lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
